Gps Wealth Strategies Group, LLC Gilead Sciences, Inc. Transaction History
Gps Wealth Strategies Group, LLC
- $747 Million
- Q4 2024
A detailed history of Gps Wealth Strategies Group, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Gps Wealth Strategies Group, LLC holds 5,172 shares of GILD stock, worth $496,667. This represents 0.06% of its overall portfolio holdings.
Number of Shares
5,172
Previous 5,539
6.63%
Holding current value
$496,667
Previous $464,000
2.8%
% of portfolio
0.06%
Previous 0.06%
Shares
17 transactions
Others Institutions Holding GILD
# of Institutions
1,990Shares Held
992MCall Options Held
10.5MPut Options Held
9.85M-
Black Rock Inc. New York, NY121MShares$11.6 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$11.1 Billion0.18% of portfolio
-
Capital World Investors Los Angeles, CA76.5MShares$7.35 Billion1.03% of portfolio
-
Capital Research Global Investors Los Angeles, CA61.8MShares$5.93 Billion1.12% of portfolio
-
State Street Corp Boston, MA60.2MShares$5.78 Billion0.21% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $120B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...